A Benner Selected Research

Therapeutics

12/2021	Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trial.
1/2019	Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine.
11/2017	Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.
1/2017	Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia.
1/2014	Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases.
4/2006	Intensive consolidation versus oral maintenance therapy in patients 61 years or older with acute myeloid leukemia in first remission: results of second randomization of the AML HD98-B treatment Trial.
2/2006	Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial.
6/2005	High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia.
11/2004	Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia.
9/2004	Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Benner Research Topics

Disease

20	Neoplasms (Cancer) 04/2024 - 02/2000
11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 08/2003
8	Multiple Myeloma 12/2007 - 08/2000
7	Colorectal Neoplasms (Colorectal Cancer) 12/2015 - 07/2000
7	Neoplasm Metastasis (Metastasis) 01/2014 - 07/2000
3	Residual Neoplasm 01/2016 - 08/2000
3	Pneumoperitoneum 01/2005 - 06/2003
3	Melanoma (Melanoma, Malignant) 12/2002 - 09/2000
2	Acute Promyelocytic Leukemia 11/2017 - 06/2005
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2015 - 01/2014
2	Leukemia 10/2015 - 02/2006
2	Breast Neoplasms (Breast Cancer) 08/2010 - 11/2000
2	Carcinoma (Carcinomatosis) 05/2005 - 03/2001
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2005 - 11/2001
2	Experimental Liver Neoplasms 01/2005 - 06/2003
2	Pathologic Complete Response 11/2004 - 08/2003
2	Hepatocellular Carcinoma (Hepatoma) 06/2003 - 02/2000
1	Adenocarcinoma 04/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024
1	Adenocarcinoma of Lung 04/2024
1	Aneuploidy (Aneuploid) 01/2023
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Primary Myelofibrosis (Myelosclerosis) 01/2017
1	Infections 01/2017
1	Neutropenia 01/2017
1	Inflammation (Inflammations) 03/2016
1	Glioma (Gliomas) 07/2007
1	Febrile Neutropenia 02/2006
1	Fever (Fevers) 02/2006
1	Microsatellite Instability 05/2005
1	Disease Progression 04/2005
1	Ulcerative Colitis 01/2005
1	Hepatitis B 11/2004
1	Glioblastoma (Glioblastoma Multiforme) 07/2004
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2003
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2003
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2003

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 10/2015 - 11/2000
5	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 08/2003
3	Biomarkers (Surrogate Marker)IBA 04/2024 - 09/2000
3	HeliumIBA 01/2005 - 06/2003
3	Interleukin-6 (Interleukin 6)IBA 08/2002 - 09/2000
3	Thalidomide (Thalomid)FDA Link 12/2001 - 09/2001
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2001 - 07/2000
3	Keratin-20 (Cytokeratin 20)IBA 01/2001 - 07/2000
2	CytokinesIBA 04/2024 - 12/2001
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2023 - 11/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 12/2001
2	AntibodiesIBA 01/2007 - 11/2003
2	Mitoxantrone (Novantrone)FDA LinkGeneric 06/2005 - 08/2003
2	GasesIBA 01/2005 - 10/2003
2	XenonIBA 01/2005 - 10/2003
2	Carbon DioxideIBA 01/2005 - 10/2003
2	N 30IBA 11/2004 - 06/2003
2	Etoposide (VP 16)FDA LinkGeneric 08/2003 - 12/2001
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 12/2001 - 09/2001
1	PlatinumIBA 04/2024
1	Cetirizine (Zyrtec)FDA LinkGeneric 01/2023
1	B7-H1 AntigenIBA 12/2021
1	Azacitidine (5 Azacytidine)FDA Link 01/2019
1	Arsenic Trioxide (Trisenox)FDA Link 11/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	pomalidomideIBA 01/2017
1	pegfilgrastim (Neulasta)FDA Link 01/2017
1	alpha-hydroxyglutarateIBA 04/2016
1	isocitric acid (isocitrate)IBA 04/2016
1	Oxidoreductases (Dehydrogenase)IBA 04/2016
1	Clodronic Acid (Clodronate)IBA 03/2016
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2015
1	Untranslated RNA (Noncoding RNA)IBA 10/2015
1	Angiopoietin-2IBA 01/2014
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 12/2008
1	Decitabine FDA Link 07/2007
1	G-Protein-Coupled Receptor Kinase 2IBA 01/2007
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2007
1	AcidsIBA 01/2007
1	Ceftazidime (Fortum)FDA LinkGeneric 02/2006
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 02/2006
1	Calcibiotic Root Canal SealerIBA 05/2005
1	AntigensIBA 05/2005
1	Core Binding Factors (Core-Binding Factor)IBA 09/2004
1	Betulinic AcidIBA 07/2004
1	CeramidesIBA 07/2004
1	Centrosomal Associated ProteinsIBA 11/2003

Therapy/Procedure

18	Therapeutics 12/2021 - 07/2000
10	Drug Therapy (Chemotherapy) 04/2024 - 12/2001
2	Adjuvant Chemotherapy 04/2024 - 08/2010
2	Stem Cell Transplantation 01/2014 - 04/2005
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 02/2006 - 10/2000
2	Homologous Transplantation 12/2005 - 04/2005
2	Liver Transplantation 11/2004 - 02/2000
1	Aftercare (After-Treatment) 11/2017
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2017
1	Cell Transplantation 01/2017
1	Hematopoietic Stem Cell Transplantation 01/2016
1	Lasers (Laser) 01/2014
1	Neoadjuvant Therapy 08/2010
1	Autologous Transplantation 12/2005
1	Immunomodulation 04/2005
1	Restorative Proctocolectomy 01/2005